• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示克罗恩病的诊断和促炎作用:来自16S引导发现和物种特异性验证的见解

Unveiling the diagnostic and pro-inflammatory role of crohn's disease: insights from 16 S-guided discovery and species-specific validation.

作者信息

Xu Yao, Xie Runxiang, Weng Yuqing, Fang Yewei, Chen Huimin, Tao Shuan, Zhang He, Ye Yawen, Deng Xinyu, Han Axiang, Jiang Qi, Liang Wei

机构信息

Department of Clinical Laboratory, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.

Health Science Center, Ningbo University, Ningbo, 315211, China.

出版信息

BMC Gastroenterol. 2025 Jul 1;25(1):468. doi: 10.1186/s12876-025-04061-0.

DOI:10.1186/s12876-025-04061-0
PMID:40597688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12211897/
Abstract

BACKGROUND

The rising incidence of Crohn's disease (CD) in Asia underscores the need to explore its underlying mechanisms. The interaction between gut microbiota and the host is strongly linked to CD onset and progression, yet the precise mechanisms remain unclear. Previous studies have demonstrated that Ruminococcus gnavus (R. gnavus) is closely associated with the development and progression of CD. Therefore, this study focuses on the inflammatory role of R. gnavus in CD pathogenesis.

METHODS

We performed comprehensive 16 S rRNA sequencing on fecal samples from active CD patients, inactive CD patients, and healthy controls. Alongside this, we conducted clinical data and correlation analyses. To identify key microbial genera, we developed and validated a random forest classification model. Additionally, we utilized a dextran sulfate sodium (DSS)-induced colitis model in C57BL/6 mice to explore the inflammatory role of R. gnavus (ATCC 29149).

RESULTS

Our analysis revealed significant shifts in gut microbiome composition across different stages of CD compared to healthy controls. Notably, there was a marked decrease in Agathobacter and an increase in R. gnavus in patients with active CD. The random forest classification model, which was based on six specific genera (Agathobacter, Vicinamibacteraceae, Arthrobacter, Eubacterium coprostanoligenes group, Ruminococcus gnavus group, and Prevotella 9), achieved an AUC of 0.912, effectively distinguishing CD patients from healthy controls. In the DSS-induced colitis model, R. gnavus exacerbated inflammation, significantly increasing levels of IL-6 and TNF-α, and significantly decreasing levels of Claudin-1 and MUC2, further underscoring its critical role in CD pathogenesis.

CONCLUSION

The identified genera demonstrate potential as diagnostic biomarkers for CD, with R. gnavus playing a key role in the disease's pathogenesis by inducing inflammation in colitis models.

摘要

背景

亚洲克罗恩病(CD)发病率的上升凸显了探索其潜在机制的必要性。肠道微生物群与宿主之间的相互作用与CD的发生和发展密切相关,但其确切机制仍不清楚。先前的研究表明,纤细瘤胃球菌(R. gnavus)与CD的发生和发展密切相关。因此,本研究聚焦于R. gnavus在CD发病机制中的炎症作用。

方法

我们对活动期CD患者、非活动期CD患者和健康对照的粪便样本进行了全面的16S rRNA测序。与此同时,我们进行了临床数据和相关性分析。为了识别关键微生物属,我们开发并验证了一个随机森林分类模型。此外,我们利用葡聚糖硫酸钠(DSS)诱导的C57BL/6小鼠结肠炎模型来探索R. gnavus(ATCC 29149)的炎症作用。

结果

我们的分析显示,与健康对照相比,CD不同阶段的肠道微生物群组成发生了显著变化。值得注意的是,活动期CD患者中阿加西杆菌明显减少,而R. gnavus增加。基于六个特定属(阿加西杆菌、维西纳米杆菌科、节杆菌、产粪甾醇真杆菌群、R. gnavus群和普雷沃菌9)的随机森林分类模型的AUC为0.912,有效地区分了CD患者和健康对照。在DSS诱导的结肠炎模型中,R. gnavus加剧了炎症,显著提高了IL-6和TNF-α水平,并显著降低了Claudin-1和MUC2水平,进一步强调了其在CD发病机制中的关键作用。

结论

所识别的属显示出作为CD诊断生物标志物的潜力,R. gnavus通过在结肠炎模型中诱导炎症在疾病发病机制中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/46258b6eb579/12876_2025_4061_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/13c4e9ebc6bb/12876_2025_4061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/f06abab97c53/12876_2025_4061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/bd76b5970423/12876_2025_4061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/3400ff80711a/12876_2025_4061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/0b61ff1e4a1d/12876_2025_4061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/46258b6eb579/12876_2025_4061_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/13c4e9ebc6bb/12876_2025_4061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/f06abab97c53/12876_2025_4061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/bd76b5970423/12876_2025_4061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/3400ff80711a/12876_2025_4061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/0b61ff1e4a1d/12876_2025_4061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0959/12211897/46258b6eb579/12876_2025_4061_Fig6_HTML.jpg

相似文献

1
Unveiling the diagnostic and pro-inflammatory role of crohn's disease: insights from 16 S-guided discovery and species-specific validation.揭示克罗恩病的诊断和促炎作用:来自16S引导发现和物种特异性验证的见解
BMC Gastroenterol. 2025 Jul 1;25(1):468. doi: 10.1186/s12876-025-04061-0.
2
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
3
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
4
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
5
Gut commensal bacteria influence colorectal cancer development by modulating immune response in AOM/DSS-treated mice.肠道共生细菌通过调节AOM/DSS处理小鼠的免疫反应影响结直肠癌的发展。
Microbiol Spectr. 2025 Jul;13(7):e0279224. doi: 10.1128/spectrum.02792-24. Epub 2025 May 16.
6
[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach.[1]炎症性肠病中的人体肠道微生物群,表征枢纽、核心微生物群和终端节点:一种基于网络的方法。
BMC Microbiol. 2025 Jun 26;25(1):371. doi: 10.1186/s12866-025-04106-0.
7
The effects of candidate probiotic strains on the gut environment in dextran sulfate sodium-induced colitis mouse.候选益生菌菌株对葡聚糖硫酸钠诱导的结肠炎小鼠肠道环境的影响。
Sci Rep. 2025 Jul 1;15(1):21103. doi: 10.1038/s41598-025-03860-5.
8
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
9
Natalizumab for induction of remission in Crohn's disease.那他珠单抗用于诱导克罗恩病缓解
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
10
Gut microbial Nordihydroguaiaretic acid suppresses macrophage pyroptosis to regulate epithelial homeostasis and inflammation.肠道微生物源去甲二氢愈创木酸抑制巨噬细胞焦亡以调节上皮稳态和炎症。
Gut Microbes. 2025 Dec;17(1):2518338. doi: 10.1080/19490976.2025.2518338. Epub 2025 Jul 1.

本文引用的文献

1
Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status.迟缓瘤胃球菌的宏基因组全球调查及深入基因组分析揭示了不同宿主生活方式和健康状况之间的差异。
Nat Commun. 2025 Jan 30;16(1):1182. doi: 10.1038/s41467-025-56449-x.
2
Agarooligosaccharides as a novel concept in prebiotics: selective inhibition of and while preserving Bifidobacteria, Lactobacillales , and inhibiting Lachnospiraceae .低聚甘露糖作为一种新型的益生元概念:选择性抑制 和 ,同时保留双歧杆菌、乳杆菌和抑制lachnospiraceae 。
Microbiology (Reading). 2024 Nov;170(11). doi: 10.1099/mic.0.001510.
3
Unveiling Ruminococcus gnavus bacteremia: Clinical characteristics and implications.
揭示迟缓瘤胃球菌菌血症:临床特征及意义
J Infect Chemother. 2025 Feb;31(2):102558. doi: 10.1016/j.jiac.2024.11.008. Epub 2024 Nov 14.
4
Screening canine sources for novel antimicrobials reveals the circular broad-spectrum bacteriocin, caledonicin, produced by .对犬类来源进行新型抗菌剂筛选,发现了由……产生的环状广谱细菌素——卡莱多霉素。
Front Microbiol. 2024 Aug 26;15:1470988. doi: 10.3389/fmicb.2024.1470988. eCollection 2024.
5
Metabolite profiling of human-originated Lachnospiraceae at the strain level.人类源毛螺菌科菌株水平的代谢物谱分析。
Imeta. 2022 Oct 13;1(4):e58. doi: 10.1002/imt2.58. eCollection 2022 Dec.
6
Pre-Diagnosis Diet Predicts Response to Exclusive Enteral Nutrition and Correlates with Microbiome in Pediatric Crohn Disease.诊断前饮食可预测小儿克罗恩病对肠内营养的反应,并与肠道微生物组相关。
Nutrients. 2024 Apr 2;16(7):1033. doi: 10.3390/nu16071033.
7
Desulfovibrio vulgaris interacts with novel gut epithelial immune receptor LRRC19 and exacerbates colitis.脱硫弧菌与新型肠道上皮免疫受体 LRRC19 相互作用并加剧结肠炎。
Microbiome. 2024 Jan 3;12(1):4. doi: 10.1186/s40168-023-01722-8.
8
Heterogeneous associations of gut microbiota with Crohn's disease activity.肠道微生物群与克罗恩病活动的异质关联。
Gut Microbes. 2024 Jan-Dec;16(1):2292239. doi: 10.1080/19490976.2023.2292239. Epub 2023 Dec 17.
9
Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.利用微生物组诊断克罗恩病和溃疡性结肠炎。
BMC Microbiol. 2023 Nov 11;23(1):336. doi: 10.1186/s12866-023-03084-5.
10
Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.炎症性肠病中的条件致病菌:起源、潜在机制及对临床治疗的影响。
Gastroenterology. 2024 Jan;166(1):44-58. doi: 10.1053/j.gastro.2023.09.019. Epub 2023 Sep 20.